Delivery Order SPE2DB20D2014-SPE2DB25FD15F
- Not listed
- The Defense Logistics Agency awarded a $1,071.90 delivery order to AmerisourceBergen Drug Corp for Xylocaine-MPF 1% vials (2ml), a local anesthetic pharmaceutical product. This firm fixed-price, non-set-aside contract was executed on September 19, 2025, with an ultimate completion date of September 22, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger federal contracting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Xylocaine-MPF 1% Vial 5ML, a local anesthetic medication commonly used in medical and surgical applications. This firm fixed-price delivery order, valued at $2,413.46, represents a non-competitive set-aside award and is scheduled for completion by August 11, 2025. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine HCL 2% 40 mg/2 mL vials on August 14, 2025, with a ceiling value of $9,369.36 and firm fixed pricing. This non-set-aside, competitively awarded contract is classified as a delivery order with an ultimate completion date of August 15, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform under this award at its corporate office location. This...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Lidocaine HCL 2% 200 mg/10 mL vials totaling $3,408.68 with a completion date of August 13, 2025. This is a firm fixed-price, non-set-aside contract with performance at the company's Conshohocken, Pennsylvania facility. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $2,272.65 delivery order to AmerisourceBergen Drug Corp for 10 milliliters of Xylocaine 2%-Epinephrine 1:200,000, a local anesthetic with vasoconstrictor properties commonly used in medical and surgical procedures. This non-set-aside, competitively awarded contract carries a firm fixed price structure with an ultimate completion date of September 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $2,536.32. The order is for the supply of XYLOCAINE-MPF 2% VIAL 2ML, a local anesthetic medication. The contract has a firm fixed price pricing type and an ultimate completion date of August 26, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for XYLOCAINE-MPF 2% 100 MG/5 ML 5ML, a pharmaceutical product, with a ceiling value of $2,008.60 and a period of performance through June 11, 2025. The contract is designated as a Firm Fixed Price contract and is not set aside for any specific business category. Amerisourcebergen Drug...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Xylocaine-MPF 2% 100 mg/5 ml, a local anesthetic medication, with a ceiling value of $1,936.18 and a period of performance through May 2, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine HCL 2% 100 mg/5 mL vials, with a contract ceiling value of $1,097.24. The award was issued on September 12, 2025, with an ultimate completion date of September 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Xylocaine-MPF 1% vial 5ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,173.76 and is a Firm Fixed Price Delivery Order with a completion date of May 24, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31,...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FD15FDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for Xylocaine-MPF 2% (40 mg/2 mL vials) with a ceiling value of $1,253.12. This non-set-aside, firm fixed-price delivery order is expected to be completed by September 29, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement under the federal medical supply chain managed by the Defense Logistics Agency. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's comprehensive IDC vehicle enables it to supply a wide range of pharmaceutical products and medical commodities to support defense health operations globally, including deliveries to the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/26/25 |